(PreOvar test) Mira Dx™ Dismisses Flawed Study as “Puzzling,” and “Comparing Apples and Oranges” | Business Wire (refers to sgo presentation/KRAS mutation variant....)

A KRAS-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk (full access)